REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $801,198 | +4.0% | 28,945 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $770,266 | +75.8% | 28,795 | +42.4% | 0.00% | +100.0% |
| Q1 2023 | $438,074 | -9.1% | 20,225 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $481,760 | +22.9% | 20,225 | +1.9% | 0.00% | 0.0% |
| Q3 2022 | $392,000 | +1.3% | 19,855 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $387,000 | -18.2% | 19,855 | +7.1% | 0.00% | 0.0% |
| Q1 2022 | $473,000 | +1.3% | 18,535 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $467,000 | -7.7% | 18,535 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $506,000 | -13.4% | 18,407 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $584,000 | -2.5% | 18,407 | +40.9% | 0.00% | 0.0% |
| Q1 2021 | $599,000 | +21.0% | 13,062 | +4.6% | 0.00% | 0.0% |
| Q4 2020 | $495,000 | – | 12,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
| Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
| Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
| Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
| Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
| TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
| Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
| Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
| Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
| BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |